Slowed vertical saccades as a hallmark of hereditary spastic paraplegia type 7.


Journal

Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278

Informations de publication

Date de publication:
10 2019
Historique:
received: 12 06 2019
revised: 28 08 2019
accepted: 29 08 2019
pubmed: 12 10 2019
medline: 8 9 2020
entrez: 12 10 2019
Statut: ppublish

Résumé

Anecdotal oculomotor disturbances have been described in spastic paraplegia type 7 (SPG7). We investigated oculomotor and vestibular dysfunction in five patients with genetically verified SPG7. All five patients exhibited significantly slower velocities of vertical saccades compared to controls, but significantly faster than in progressive supranuclear palsy, with upward saccades being particularly affected. Horizontal saccades, cerebellar oculomotor markers, and vestibuloocular reflex seem to be variably affected. Thus, albeit subclinical in some cases, slowing of the vertical saccades may belong to the phenotype of SPG7 and may serve as a valuable biomarker for differentiation from spastic ataxias and atypical parkinsonism.

Identifiants

pubmed: 31602813
doi: 10.1002/acn3.50907
pmc: PMC6801205
doi:

Substances chimiques

Biomarkers 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2127-2132

Informations de copyright

© 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.

Références

Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
Neurol Sci. 2012 Dec;33(6):1225-32
pubmed: 22810120
IEEE Trans Biomed Eng. 2008 Dec;55(12):2840-2
pubmed: 19126467
Mov Disord Clin Pract. 2018 Dec 06;6(2):174-175
pubmed: 30838319
Neurology. 2015 Mar 17;84(11):1174-6
pubmed: 25681447
Neurology. 2001 Feb 27;56(4):467-71
pubmed: 11222789
J Neurol. 2014 Sep;261 Suppl 2:S542-58
pubmed: 25145891
Arch Neurol. 1964 Apr;10:333-59
pubmed: 14107684
Cerebellum. 2017 Apr;16(2):525-551
pubmed: 27271711
Parkinsonism Relat Disord. 2018 Feb;47:88-90
pubmed: 29246844
J Neurol. 2008 Aug;255(8):1142-4
pubmed: 18563470
Neurology. 2007 Jul 24;69(4):368-75
pubmed: 17646629
Int J Mol Sci. 2015 Oct 21;16(10):25050-66
pubmed: 26506339
Neurology. 2006 Mar 14;66(5):654-9
pubmed: 16534102
Lancet. 1983 May 21;1(8334):1151-5
pubmed: 6133167
Dement Geriatr Cogn Disord. 2002;13(4):235-43
pubmed: 12006734
Front Neurol. 2019 May 24;10:508
pubmed: 31231294

Auteurs

Ivan Milenkovic (I)

Department of Neurology, Medical University of Vienna, Vienna, Austria.

Sigrid Klotz (S)

Department of Neurology, Medical University of Vienna, Vienna, Austria.

Gudrun Zulehner (G)

Department of Neurology, Medical University of Vienna, Vienna, Austria.

Thomas Sycha (T)

Department of Neurology, Medical University of Vienna, Vienna, Austria.

Gerald Wiest (G)

Department of Neurology, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH